In a retrospective cohort study, anticoagulants did not protect against the significantly increased risk for venous thromboembolism resulting from the use of erythropoiesis-stimulating agents. Medscape Medical News
Ivabradine was no better than placebo in terms of reducing cardiac death and other coronary and heart-failure outcomes in the overall trial population; however, patients with heart rates higher than 70 bpm had reduced hospitalizations for heart failure and MI and reduced revascularizations with ivabradine. Heartwire
Patients with hypertension who monitored their blood pressure from home and received Web-based pharmacist care showed greater improvement in blood pressure control than patients who had usual care. Medscape Medical News
A new analysis has confirmed that low baseline systolic blood-pressure levels and changes in systolic blood pressure over time are risk factors for adverse events in heart-failure patients. Medscape Medical News
